Chris Roberts
Director/Board Member chez SIGMA HEALTHCARE LIMITED
Fortune : 39 M $ au 31/03/2024
Profil
Christopher Graham Roberts is currently the Chairman of TEDI-London.
He is also a Non-Executive Director at Sigma Healthcare Ltd., a Director at Cochlear Foundation Ltd., a Non-Executive Director at Clarity Pharmaceuticals Ltd., a Director at Nutromics Pty Ltd., a Non-Executive Director at Atmo Biosciences Ltd., an Independent Non-Executive Director at HealthCo Healthcare & Wellness REIT, a Non-Executive Director at Hmc Capital Partners Fund I, and a Professor at Arizona State University, The University of New South Wales, and King's College London.
He is a Member of the Governors Board at Centenary Institute and a Member of Innovation Australia.
Formerly, Dr. Roberts served as the President, CEO & Executive Director of Cochlear Ltd.
from 2004 to 2015.
He was also the Chairman of Sirtex Medical Pty Ltd.
from 2000 to 2002, the Executive Chairman of OncoSil Medical Ltd.
from 2016 to 2021, the Chairman of Research Australia Ltd.
from 2004 to 2010, the President, Director & Executive Vice President of ResMed, Inc. from 1992 to 2017, the President of BGS Medical from 1976 to 1992, and a Member of the National Health & Medical Research Council from 2003 to 2006.
Dr. Roberts completed his undergraduate and doctorate degrees at The University of New South Wales and holds an MBA from Macquarie University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
COCHLEAR LIMITED
0,26% | 28/07/2023 | 172 387 ( 0,26% ) | 38 M $ | 31/03/2024 |
| 04/12/2023 | 1 029 405 ( 0,18% ) | 852 914 $ | 31/03/2024 | |
SIGMA HEALTHCARE LTD
0,00% | 08/04/2024 | 8 353 ( 0,00% ) | 7 057 $ | 31/03/2024 |
Postes actifs de Chris Roberts
| Sociétés | Poste | Début |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Director/Board Member | 01/03/2016 |
| HEALTHCO HEALTHCARE AND WELLNESS REIT | Director/Board Member | 01/08/2021 |
| SIGMA HEALTHCARE LIMITED | Director/Board Member | 06/10/2023 |
| Arizona State University | Corporate Officer/Principal | - |
| TEDI-London | Chairman | - |
Nutromics Pty Ltd.
 Nutromics Pty Ltd. Information Technology ServicesTechnology Services Nutromics Pty Ltd. provides data science and health care services. It offers digital health platform using real time molecular biomarkers, starting with diabetes. The company was founded by Peter Vranes in 2017 and is headquartered in Melbourne, Australia. | Director/Board Member | - |
Atmo Biosciences Ltd.
 Atmo Biosciences Ltd. Electronic Equipment/InstrumentsElectronic Technology Atmo Biosciences Ltd. manufactures a gas-sensing capsule sensor. | Director/Board Member | - |
| Cochlear Foundation Ltd. | Director/Board Member | - |
Centenary Institute
 Centenary Institute Miscellaneous Commercial ServicesCommercial Services Centenary Institute operates as an independent medical research institute independent medical research institute. The firm offers research on cancer, inflammation, cardiovascular, research programs, laboratories and resources. The company was founded in 1982 and is headquartered in Camperdown, Australia. | Director/Board Member | 01/04/2015 |
| ░░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de Chris Roberts
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Chris Roberts
| The University of New South Wales | Doctorate Degree |
| Macquarie University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| RESMED, INC. | Health Technology |
| COCHLEAR LIMITED | Health Technology |
| ONCOSIL MEDICAL LIMITED | Health Technology |
| SIGMA HEALTHCARE LIMITED | Health Technology |
| CLARITY PHARMACEUTICALS LTD | Health Technology |
| HEALTHCO HEALTHCARE AND WELLNESS REIT | Finance |
| Entreprise privées | 11 |
|---|---|
Sirtex Medical Pty Ltd.
 Sirtex Medical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Sirtex Medical Ltd. manufactures, and distributes liver cancer treatments. It operates through the following geographical segments: Asia Pacific, Americas, and Europe, Middle East, and Africa. It offers targeted radiation therapy known as SIR Spheres Y-90 resin microspheres. The company was founded in 1997 and is headquartered in St Leonards, Australia. | Commercial Services |
| Research Australia Ltd. | |
| BGS Medical | |
| National Health & Medical Research Council | Government |
Centenary Institute
Centenary Institute Miscellaneous Commercial ServicesCommercial Services Centenary Institute operates as an independent medical research institute independent medical research institute. The firm offers research on cancer, inflammation, cardiovascular, research programs, laboratories and resources. The company was founded in 1982 and is headquartered in Camperdown, Australia. | Commercial Services |
| Cochlear Foundation Ltd. | |
| TEDI-London | |
Nutromics Pty Ltd.
Nutromics Pty Ltd. Information Technology ServicesTechnology Services Nutromics Pty Ltd. provides data science and health care services. It offers digital health platform using real time molecular biomarkers, starting with diabetes. The company was founded by Peter Vranes in 2017 and is headquartered in Melbourne, Australia. | Technology Services |
Atmo Biosciences Ltd.
Atmo Biosciences Ltd. Electronic Equipment/InstrumentsElectronic Technology Atmo Biosciences Ltd. manufactures a gas-sensing capsule sensor. | Electronic Technology |
Hmc Capital Partners Fund I
 Hmc Capital Partners Fund I Financial ConglomeratesFinance Part of HMC Capital Ltd., Hmc Capital Partners Fund I operates as an investment fund. The private company is based in Sydney, Australia. | Finance |
| Innovation Australia |
